MegaMD Co., Ltd.

KOSDAQ:A133750 Stock Report

Market Cap: ₩37.9b

MegaMD Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for MegaMD.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Consumer Services earnings growth19.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article Apr 08

MegaMD Co., Ltd.'s (KOSDAQ:133750) 27% Price Boost Is Out Of Tune With Revenues

The MegaMD Co., Ltd. ( KOSDAQ:133750 ) share price has done very well over the last month, posting an excellent gain of...
Analysis Article Mar 28

MegaMD's (KOSDAQ:133750) Solid Earnings Are Supported By Other Strong Factors

MegaMD Co., Ltd. ( KOSDAQ:133750 ) announced strong profits, but the stock was stagnant. We did some digging, and we...
Analysis Article Nov 13

MegaMD (KOSDAQ:133750) Is Looking To Continue Growing Its Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Analysis Article Aug 08

A Look At The Intrinsic Value Of MegaMD Co., Ltd. (KOSDAQ:133750)

Key Insights Using the 2 Stage Free Cash Flow to Equity, MegaMD fair value estimate is ₩1,874 MegaMD's ₩1,908 share...
Analysis Article Apr 18

Some MegaMD Co., Ltd. (KOSDAQ:133750) Shareholders Look For Exit As Shares Take 25% Pounding

MegaMD Co., Ltd. ( KOSDAQ:133750 ) shareholders won't be pleased to see that the share price has had a very rough...
Analysis Article Feb 26

MegaMD Co., Ltd.'s (KOSDAQ:133750) Popularity With Investors Is Under Threat From Overpricing

When close to half the companies in the Consumer Services industry in Korea have price-to-sales ratios (or "P/S") below...
Analysis Article Apr 05

Is MegaMD Co., Ltd. (KOSDAQ:133750) The Right Choice For A Smart Dividend Investor?

Could MegaMD Co., Ltd. ( KOSDAQ:133750 ) be an attractive dividend share to own for the long haul? Investors are often...
Analysis Article Mar 09

Is MegaMD Co., Ltd.'s (KOSDAQ:133750) Recent Price Movement Underpinned By Its Weak Fundamentals?

MegaMD (KOSDAQ:133750) has had a rough three months with its share price down 11%. It seems that the market might have...
Analysis Article Feb 08

MegaMD (KOSDAQ:133750) Shareholders Booked A 44% Gain In The Last Three Years

By buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger...
Analysis Article Jan 14

What Do The Returns On Capital At MegaMD (KOSDAQ:133750) Tell Us?

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...
Analysis Article Dec 24

Read This Before Considering MegaMD Co., Ltd. (KOSDAQ:133750) For Its Upcoming ₩50.00 Dividend

MegaMD Co., Ltd. ( KOSDAQ:133750 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...
Analysis Article Dec 08

Is MegaMD Co., Ltd. (KOSDAQ:133750) A Great Dividend Stock?

Today we'll take a closer look at MegaMD Co., Ltd. ( KOSDAQ:133750 ) from a dividend investor's perspective. Owning a...
Analysis Article Nov 17

Are MegaMD's (KOSDAQ:133750) Statutory Earnings A Good Guide To Its Underlying Profitability?

Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MegaMD has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A133750 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202535,1933,1413,9274,973N/A
3/31/202536,1622,6714,8435,735N/A
12/31/202436,4913,7838,0988,387N/A
9/30/202436,0891,5068,6058,693N/A
6/30/202435,8401,3166,3686,811N/A
3/31/202436,0604214,6475,213N/A
12/31/202336,041-3,197-1,4281,055N/A
9/30/202337,370-5,549-5,327-2,272N/A
6/30/202343,915-5,140-12,678-9,799N/A
3/31/202354,107-2,449-15,316-12,056N/A
12/31/202264,4682,113-10,009-8,260N/A
9/30/202270,4813,6416702,851N/A
6/30/202274,3285,8699,58612,253N/A
3/31/202277,1996,73710,85213,314N/A
12/31/202179,4356,65015,77117,945N/A
9/30/202181,3646,65715,13816,629N/A
6/30/202182,7245,87317,63021,018N/A
3/31/202182,3956,19616,27719,687N/A
12/31/202082,4404,89712,19816,030N/A
9/30/202081,3563,95213,06116,867N/A
6/30/202079,9992,76813,22715,357N/A
3/31/202080,1809596,6469,440N/A
12/31/201980,3744137,2889,691N/A
9/30/201980,362-9436,91110,359N/A
6/30/201978,330-9844,6187,498N/A
3/31/201976,491-278N/A10,295N/A
12/31/201875,3281,110N/A14,975N/A
9/30/201873,04557N/A19,992N/A
6/30/201873,156-493N/A13,823N/A
3/31/201870,822-1,834N/A13,272N/A
12/31/201769,202-1,885N/A7,603N/A
9/30/201762,756804N/A1,044N/A
6/30/201762,5281,097N/A3,642N/A
3/31/201760,6211,813N/A6,401N/A
12/31/201660,0763,138N/A5,007N/A
9/30/201663,4373,062N/A7,527N/A
6/30/201662,4994,587N/A8,482N/A
3/31/201665,6377,331N/A11,353N/A
12/31/201566,9368,757N/A18,125N/A
9/30/201567,8858,433N/A15,236N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A133750's forecast earnings growth is above the savings rate (3.1%).

Earnings vs Market: Insufficient data to determine if A133750's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A133750's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A133750's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A133750's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A133750's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/17 20:57
End of Day Share Price 2026/05/15 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MegaMD Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.